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The possible similarities of the mechanism by which vinblastine induces autophagocytosis in liver were 
compared with the known effects of glucagon in glucagon-induced autophagocytosis. A single 
intraperitoneal injection of vinblastine produced a wave of autophagocytosis in co.5 h in mouse 
hepatocytes. Liver glycogen content decreases imultaneously and blood glucose first increased and then 
decreased below control values. Both liver CAMP concentration and the activity of glycogen phosphorylase 
remained unchanged. These findings provide evidence that the induction of autophagocytosis after 
vinblastine injection is not mediated by CAMP. The increased degradation of glycogen may occur in the 
lysosomal system by means of increased autophagocytosis. 
Vinoblastine Autophagocytosis 
1. INTRODUCTION 
In autophagocytosis cells digest their own orga- 
nelles in membrane-limited vacuoles by means of 
lysosomal enzymes. Recently, it has been found 
that this mechanism is also the main system for 
protein degradation in the liver [1,2]. During 
studies of cellular autophagocytosis everal experi- 
mental methods have been used [3-51 in order to 
increase the formation of autophagic vacuoles 
(AV), which occur rather infrequently in normal 
cells [9]. The classical method of inducing auto- 
phagocytosis is intraperitoneal injection of gluca- 
gon, which increases autophagocytosis within 
30 min in rat hepatocytes [3,6]. Some evidence has 
been presented that the true inducer might be the 
elevated liver cyclic AMP (CAMP) concentration 
caused by glucagon injection, since dibutyryl 
CAMP alone has been implicated in the induction 
of autophagocytosis [7]. 
The microtubule inhibitor vinblastine has also 
proved to be a powerful inducer of autophagocyto- 
sis [8,9]. The mechanism by which vinblastine 
induces autophagocytosis is not clear. It has been 
shown that vinblastine increased the pituitary 
CAMP concentration by inhibition of CAMP phos- 
Liver Glycogen CAMP 
phodiesterase. Although vinblastine usually in- 
hibits secretory processes, it actually stimulates the 
release of glucagon from the pancreas, at least in 
vitro [ll]. 
This study was undertaken in order to elucidate 
any possible similarities in the mechanisms by 
which vinblastine and glucagon induce autophago- 
cytosis. For this purpose the effects of an intraperi- 
toneal injection of vinblastine on mouse liver 
CAMP and glycogen as well as on blood glucose 
levels were studied. The activity of liver glycogen 
phosphorylase was also estimated. The ultrastruc- 
tural changes of hepatocytes were monitored by 
electron microscopy. 
2. MATERIALS AND METHODS 
2.1. Experimental animals 
150 male NMRI-mice (2-3 months old, 27-34 g 
body wt) were used in the experiments. Animal 
care was conducted as in [4]. Vinblastine sulphate 
(E. Lilly, Indianapolis IN) was dissolved in 0.9% 
saline, and injected as a single intraperitoneal dose 
of 10 mg/kg body wt. Control animals received a 
corresponding volume of saline. The animals were 
divided into 3 groups which were fed in different 
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ways during the experiments. One group starved 
overnight (12 h), the second group starved after 
the administration of vinblastine or saline, and the 
third group was given food ad libitum. Liver glyco- 
gen estimations were made from all 3 groups, 
blood glucose from the first and third groups, and 
estimations of CAMP concentration and glycogen 
phosphorylase a activity, as well as specimens for 
electron microscopy, were made from the third 
group. 
2.2. Assay procedures 
Specimens for electron microscopy were pre- 
pared as in [4] and examined in a JEM 100 U elec- 
tron microscope. Cyclic AMP concentration was 
assayed as in [12] with the reagents and instruc- 
tions of Boehringer Mannheim GmbH. Radio- 
activity was determined using an LKB (Wallac) 
liquid scintillation counter. Blood glucose was esti- 
mated by the o-toluidine method as in [13] and 
liver glycogen level was estimated using anthrone 
reagent [14]. Estimation of liver glycogen phos- 
phorylase a activity was carried out by measure- 
ment of the rate of liberation of inorganic phos- 
phate from glucose l-phosphate in the presence of 
glycogen; i.e., in the direction of synthesis of gly- 
cogen [15,16] as follows: a lo%-homogenate (w/v) 
was made in ice-cold 0.1 M glycylglycine buffer 
(pH 7.4) containing 0.15 M NaF in order to inhibit 
phosphorylase activity. Caffeine (final concentra- 
tion 0.5 mM: inhibits phosphorylase b activity) 
was also added to the homogenate. The substrate 
solution contained 1% glycogen, 50 mM glucose 
l-phosphate and 0.15 M NaF. The incubation was 
performed at 37°C for 10 min and the reaction was 
stopped by adding 10% TCA. The mixture was 
centrifuged and the supernatant was used for the 
determination of inorganic phosphate [ 171. 
Satatistical analysis was performed using Stu- 
dent’s t-test. 
3. RESULTS 
3.1. Vinblastine-induced autophagocytosis 
As early as 30 min after vinblastine injection 
several newly formed, double membrane-limited 
Fig.1. Mouse hepatocytes 1 h after vinblastine injection (10 mg/kg). Several autophagosomes (AV) with variable 
contents can be seen in the cytoplasm. Arrow: Cytoplasmic glycogen, BC: Bile canalisulus. M: x12000. Inset: An 
autophagosome containing glycogen granules. M: x30000. 
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Fig.2. Mouse hepatocytes 12 h after vinblastine injection (10 mg/kg). Autophagosomes (AV) with partially degraded 
contents can be seen around the bile canaliculus (BC). No glycogen can be seen in the cytoplasm. M: x 15000. 
AV were observed in the cytoplasm of the hepato- 
cytes. The contents of the vacuoles were variable 
including glycogen and various cell organelles 
(fig.l,2) as in [4]. Glycogen was observed in the 
hepatocytes of the freely feeding animals, but dis- 
appeared completely during the 4 h after injection 
(fig.2). Other ultra-structural changes also occur- 
red in the hepatocytes after vinblastine administra- 
tion. These changes have been described in [4]. 
3.2. Biochemical assays 
Blood glucose level was significantly elevated 1 h 
after vinblastine administration. This elevation 
was reversed after 2 h in the group which had free 
access to food (fig.3). The results expressed in fig.4 
show that the liver glycogen content decreased 
significantly 1 or 2 h after injection in the group of 
animals which was starved after injection as well as 
in the freely feeding group, respectively. The 
CAMP concentrations in the livers of the animals 
receiving vinblastine did not differ significantly 
from the control values (table 1). The glycogen 
phosphorylase a activity also showed no significant 
changes after vinblastine injection (table 2). 
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Fig.3. Blood glucose levels in mice after vinblastine 
(10 mg/kg; circles) or saline (squares) injection. Open 
symbols denote that the animals had free access to food 
throughout the experiment. Filled symbols denote that 
the animals were starved overnight before killing. Each 
symbol is the mean value of 4 animals. The vertical bars 
indicate the standard error. Levels of significance as 
compared with controls: +, p < 0.050; ++, p < 0.010; 
+++, p < 0.001. 
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Fig.4. Mouse liver glycogen levels 1, 2, 4 and 12 h after vinblastine (10 mg/kg, black columns) or saline (white columns) 
injection. Each column represents the mean value from 4 animals. The vertical bars indicate the standard error. Levels 
of significance as compared with controls: +, p < 0.050; ++, p < 0.010; +++, p < 0.001. 
Table 1 
Cyclic AMP content of mouse liver 15,30 and 60 min after VBL injection (10 mg/kg) as com- 
pared with controls 
Treatment Saline Time after VBL injection (min) 
15 30 60 
pmol/mg 0.423 * 0.007 0.386 + 0.039 0.408 f 0.020 0.416 +0.039 
n 6 6 6 6 
Results are expressed as pmol cAMP/mg wet wt of liver tissue. Values given are means +_ stan- 
dard error 
Table 2 
Glycogen phosphorylase a activity in mouse liver 15, 30 and 60 min after VBL injection 
(10 mg/kg) as compared with controls 
Treatment Saline Time after VBL injection (min) 
15 30 60 
pm01 .min-’ . g protein-’ 122 f 6.56 113 + 6.39 119 * 3.91 120 f 5.72 
n 8 8 8 8 
Results are expressed aspmol liberated Pi. min-’ . g protein-‘. Values given are means f stan- 
dard error 
4. DISCUSSION 
Blood glucose values were elevated 1 h after vin- 
blastine injection, resembling the sharp rise in 
blood glucose typical for glucagon-stimulated gly- 
Injection of vinblastine to the test animals was 
followed by a loss of glycogen from the liver. 
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cogenolysis [181. The hypoglycemic activity of vin- 
blastine later observed in the group of animals 
feeding freely has been described in [19]. 
There are two principal enzymatic pathways by 
which glycogen can be degraded to glucose in the 
liver: by glycogen phosphorylase in the cytoplasm 
and by a-glucosidase in the lysosomal system. 
Phosphorolysis is involved in the rapid breakdown 
of glycogen when glucose or glucose phosphates 
are required for the energy needs of the body. The 
lysosomal a-glucosidase is necessary when glyco- 
gen is engulfed in AV [20]. According to our results 
increased glycogen degradation due to glycogen 
phosphorylase activation appeared to be improb- 
able, because this enzyme is activated by elevated 
CAMP levels in the liver. Glucagon inreases the 
CAMP content in isolated rat liver within few min 
[21,22]. Here, neither the CAMP level nor the 
glycogen phosphorylase a activity changed after 
vinblasting injection. Furthermore, it has been 
found [23] that vinblastine and colchicine inhibit- 
glucagon-stimulated adenylate cyclase and CAMP 
phosphodiesterase in rat liver plasma membrane. 
Inhibition of adenylate cyclase activity could thus 
explain the unchanged CAMP concentrations after 
vinblastine injection in his study despite the possi- 
ble inhibition of CAMP phosphodiesterase activity, 
which could otherwise lead to increased CAMP 
concentrations as in the pituitary [lo]. Unchanged 
CAMP levels have also been observed in 
autophagocytosis induced by amino acid depriva- 
tion in perfused rat liver, when glycogen was 
simultaneously frequently found in AV [5]. 
It has been shown that the uptake of cytoplasmic 
proteins by autolysosomes apears to be an obliga- 
tory step in proteolysis at all levels of regulation. 
As much as 99% of the intracellular proteins of the 
hepatocytes may be degraded in autolysosomes 
[1,2]. According to our results the increased degra- 
dation of glycogen after vinblastine injection may 
occur in the lysosomal system by means of in- 
creased autophagocytosis. The results also show 
that vinblastine induces autophagocytosis indepen- 
dently of alterations in the level of liver CAMP. 
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